Soy Saponins Meditate the Progression of Colon Cancer in Rats by Inhibiting the Activity of β-Glucuronidase and the Number of Aberrant Crypt Foci but Not Cyclooxygenase-2 Activity

Objective. The effect of extracted crude soybean saponins on preneoplastic lesions, aberrant crypt foci (ACF), and the related mechanism were investigated. Research Methods and Procedures. Rats were assigned into five groups according to different doses of extracted crude soybean saponins and received 1,2-dimethylhydrazine (DMH) injection in week 5. In week 15, all rats were sacrificed. The number of ACFs, the cyclooxygenase-2 (COX-2) protein expression, the level of prostaglandins E2 (PGE2), and the activity of β-glucuronidase were examined. Results. Results revealed that the consumption of extracted crude soybean saponins decreased the number of ACFs and the activity of β-glucuronidase in rats, while the expression of COX-2 protein and PGE2 level were not affected. Conclusions. Soybean saponins were effective in inhibiting colon cancer by downregulating the activity of β-glucuronidase in colonic mucosa but not the COX-2 protein expression and PGE2 level.

[1]  A. Bode,et al.  6,7,4'-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2. , 2011, Carcinogenesis.

[2]  Cheng-Yu Tsai,et al.  Effect of soy saponin on the growth of human colon cancer cells. , 2010, World journal of gastroenterology.

[3]  K. Yamaguchi,et al.  Plasma membrane‐associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane‐treated transgenic mice , 2009, Cancer science.

[4]  Jayadev Raju,et al.  Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta. , 2009, The Journal of nutrition.

[5]  Sei-Jung Lee,et al.  Glycine- and proline-rich glycoprotein regulates the balance between cell proliferation and apoptosis for ACF formation in 1,2-dimethylhydrazine-treated A/J mice , 2009, Molecular and Cellular Biochemistry.

[6]  Mi-Kyung Sung,et al.  Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2. , 2008, Cancer letters.

[7]  M. Murkovic,et al.  Beta-glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. , 2007, Carcinogenesis.

[8]  Jun Wang,et al.  Genistein chemoprevention of prostate cancer in TRAMP mice , 2007, Journal of carcinogenesis.

[9]  A. Biggeri,et al.  Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. , 2007, Cancer research.

[10]  N. Suh,et al.  Pterostilbene, an Active Constituent of Blueberries, Suppresses Aberrant Crypt Foci Formation in the Azoxymethane-Induced Colon Carcinogenesis Model in Rats , 2007, Clinical Cancer Research.

[11]  Cheng-Yu Tsai,et al.  Effects of soy components on blood and liver lipids in rats fed high-cholesterol diets. , 2005, World journal of gastroenterology.

[12]  P. Lirk,et al.  Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. , 2005, Seminars in cancer biology.

[13]  Allison A Ellington,et al.  Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins. , 2004, Carcinogenesis.

[14]  S. Kerwin.  Soy saponins and the anticancer effects of soybeans and soy-based foods. , 2004, Current medicinal chemistry. Anti-cancer agents.

[15]  Hye-Youn Cho,et al.  Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. , 2004, The Journal of nutritional biochemistry.

[16]  P. Dolara,et al.  Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. , 2003, Cancer research.

[17]  E. Matos,et al.  Review on meat consumption and cancer in South America. , 2002, Mutation research.

[18]  B. Evers,et al.  Inflammation and the development of pancreatic cancer. , 2002, Surgical oncology.

[19]  Denis E. Corpet,et al.  Most Effective Colon Cancer Chemopreventive Agents in Rats: A Systematic Review of Aberrant Crypt Foci and Tumor Data, Ranked by Potency , 2002, Nutrition and cancer.

[20]  Jun Wang,et al.  Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  Dong-Hyun Kim,et al.  Intestinal bacterial β-glucuronidase activity of patients with colon cancer , 2001 .

[22]  Rajnish A. Gupta,et al.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 , 2001, Nature Reviews Cancer.

[23]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[24]  J. Botting.  Defining the role of COX-2 inhibitors in inflammatory and other diseases. , 2000, Drug news & perspectives.

[25]  A. Hara,et al.  Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. , 2000, Cancer research.

[26]  R P Bird,et al.  The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. , 2000, Toxicology letters.

[27]  M. Inoue,et al.  Development and Distribution of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]‐pyridine (PhIP)‐induced Aberrant Crypt Foci in the Rat Large Intestine , 1999, Japanese journal of cancer research : Gann.

[28]  A. Rao,et al.  Saponins as anticarcinogens. , 1995, The Journal of nutrition.

[29]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[30]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[31]  B. Reddy,et al.  Effect of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. , 1992, Gastroenterology.

[32]  E. Wynder,et al.  Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial beta-glucuronidase activity in F344 rats. , 1977, Cancer research.

[33]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  I. Tabata,et al.  Effect of running training on DMH-induced aberrant crypt foci in rat colon. , 2007, Medicine and science in sports and exercise.

[35]  Y. Cha,et al.  Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet. , 2006, Journal of medicinal food.

[36]  中村 穣.  Comparison of four microbial enzymes in clostridia and bacteroides isolated from human feces , 2003 .

[37]  T. P. Pretlow,et al.  Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. , 2001, Cancer research.

[38]  K. Wakabayashi.  NSAIDs as Cancer Preventive Agents. , 2000, Asian Pacific journal of cancer prevention : APJCP.

[39]  K. Wakabayashi,et al.  COX-2 and iNOS, good targets for chemoprevention of colon cancer. , 2000, BioFactors.

[40]  F. Bornet,et al.  Effects of resistant starch- and vitamin A-supplemented diets on the promotion of precursor lesions of colon cancer in rats. , 1997, Nutrition and cancer.

[41]  I. Cameron,et al.  The nonfermentable dietary fiber lignin alters putative colon cancer risk factors but does not protect against DMH-induced colon cancer in rats. , 1997, Nutrition and cancer.

[42]  G. S. Sidhu,et al.  Could saponins be a useful treatment for hypercholesterolaemia? , 1990, European journal of clinical nutrition.